Context Therapeutics Inc.CNTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+23.9%
5Y CAGR+234.2%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+23.9%/yr
Annual compound
5Y CAGR
+234.2%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
416.7x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$94.43M+553.5%
2023$14.45M-59.3%
2022$35.50M-28.5%
2021$49.64M+14454.2%
2020$341037.00+50.5%
2019$226603.00-